Non-alcoholic fatty liver disease (NAFLD) represents the most common cause of liver dysfunction around the world, found on imaging in 20%-35% of adults. The spectrum of NAFLD includes simple hepatic steatosis, non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and liver cancer. 1 The pathogenesis of NAFLD is complex and multifactorial. Genetic, metabolic and environmental factors are involved in the accumulation of fat in hepatocytes. 2 It has been reported that overweight/obesity, insulin resistance (IR), type 2 diabetes and dyslipidaemia are the well-known leading causes of NAFLD. 3 The liver closely communicates with adipose tissue. Steatosis results from a combination of adipose tissue dysfunction and lipid metabolism dysregulation in the liver in an IR status. 4 In addition to energy storage, adipose tissue exerts other substantial functions, for example affecting systemic energy homeostasis by the endocrine system. 5 Adipose tissue secretes a wide variety of bioactive substances, known as adipokines, which dysregulated secretion of